Varian

Aspekt Solutions strives to provide the highest quality professional services with core competency in medical and industrial radiation applications - including technical expertise for consultation, development and management of applied radiation systems, including staffing and management solutions to clinics and hospitals in the business of providing radiation services. AMP has the following staff and support available for services: Clinical and Support Staff: Qualified Medical Physics (QMP) staff Qualified Medical Dosimetry staff Authorized Medical Physicist staff for licensed RAM procedures Radiation Safety Officer staff for RAM licenses Medical Health Physics staff for medical applications Medical Administrative Support staff for Accreditation Programs Qualified Experts and Licensed Inspectors (State recognized) Support and Equipment: Full Complement of Equipment for testing of: Diagnostic X-ray (Planar, Digital, CT, MRI) Nuclear Medicine (Gamma Cameras and PET systems) Health Physics needs in Nuclear Medicine Shielding Audits Full Complement of Equipment for support of: Acceptance and Commissioning of Linacs Acceptance and Commissioning of SRS systems Patient Dosimetry (OSL) Film Dosimetry (QA) LDR Prostate Seed Dosimetry

Lucata Corporation specializes in developing advanced hardware and software technology to enhance memory utilization for various industries. Founded in 2008 and headquartered in New York, with additional offices in South Bend, Indiana, and Palo Alto, Lucata produces motherboards, node cards, and memory servers designed for high-performance analytics. The company employs patented migrating thread technology to enable organizations to perform extensive multi-hop analytics and graph analysis on massive databases, facilitating insights from complex data structures with up to one trillion vertices. Lucata's solutions cater to sectors such as financial services, cybersecurity, healthcare, and telecommunications, allowing users to leverage existing graph database software for deeper analysis without the need for extensive software layers. The company's architecture is energy-efficient, supports linear performance scaling, and significantly reduces latency, making it a powerful option for organizations tackling big data challenges.

Bendit is a medical company focused on the development and manufacturing of innovative catheters that utilize a unique bending technology, allowing for enhanced steering capabilities in both micro diameter and traditional catheter designs. The company specializes in creating microcatheter devices that facilitate optimal navigation within the body, particularly in challenging anatomical areas. Bendit's products are designed to improve procedural efficiency by enabling healthcare professionals to reach target sites with fewer tools, thereby reducing risks and increasing the likelihood of successful outcomes. The organization is a joint venture comprising three experienced groups that bring expertise in production, quality and regulation, and medical development.

COTA was founded in 2011 by doctors, engineers, and data scientists to create clarity from fragmented and often-inaccessible real world data. By using proprietary technology, advanced analytics and deep expertise to organize complex data, COTA provides a comprehensive picture of cancer that can be used to advance care and research.

HistoSonics, Inc. is a medical technology company based in Plymouth, Minnesota, specializing in non-invasive tumor ablation systems. The company has developed the Edison Platform, which employs advanced imaging and proprietary sensing technology to deliver precise sonic beam therapy. This innovative platform utilizes histotripsy and focused sound energy to liquefy and destroy targeted tissues at the sub-cellular level, enabling personalized treatments. HistoSonics' technology allows physicians to monitor the treatment in real time, offering a safe alternative to traditional interventional and surgical methods, minimizing undesirable side effects often associated with these approaches. Incorporated in 2009, HistoSonics aims to enhance treatment outcomes through its pioneering non-invasive solutions.

Arterys Inc. is a technology company that specializes in developing a cloud-based analytics platform designed to enhance medical imaging diagnostics. Founded in 2007 and headquartered in San Francisco, California, with additional offices in Calgary and Paris, Arterys offers a range of artificial intelligence solutions, including Cardio AI for cardiac image analysis, Lung AI for lung imaging, and Liver AI for liver assessments. Their platform provides radiologists with tools to visualize and quantify blood flow in the human body, facilitating improved patient care through advanced imaging techniques. The Arterys PHI Service allows physicians to access patient data remotely, enhancing the efficiency of medical practice. As a pioneer in internet-based medical imaging, Arterys combines web accessibility with FDA-cleared AI technology to deliver innovative clinical solutions aimed at transforming healthcare.

Zap Surgical Systems, Inc. is a medical technology company based in San Carlos, California, founded in 2014. The company designs and manufactures the ZAP-X radiosurgery platform, which is utilized for treating brain tumors and various conditions affecting the head and neck. This innovative system features a self-shielded design that eliminates the necessity for traditional radiation vaults, allowing for greater accessibility and point-of-care delivery in settings such as physician offices, ambulatory surgery centers, and satellite facilities. By enabling neurosurgeons and radiation oncologists to utilize precision radiation more effectively, Zap Surgical Systems aims to enhance treatment options for patients requiring advanced surgical interventions.

Oncora Medical, Inc. is a digital health company focused on enhancing radiation oncology through an innovative analytics platform. Founded in 2014 and based in Philadelphia, Pennsylvania, the company provides tools that facilitate the integration of clinical data from electronic medical records, treatment planning software, and oncology information systems. This allows radiation oncologists to make personalized treatment recommendations based on historical data and predictive analytics. The platform also employs machine learning algorithms to analyze patient outcomes, enabling oncologists to improve cancer care and optimize treatment strategies. By leveraging real-world data, Oncora Medical aims to support better healthcare decisions and ultimately enhance patient outcomes in radiation oncology.

Endocare, Inc. develops, manufactures, and distributes medical devices and related consumables for cryoablation.

Cancer Treatment Services International (CTSI) is a provider of comprehensive clinical and administrative solutions for cancer treatment and other complex diseases. Established in 2006 and headquartered in Pittsburgh, Pennsylvania, the company operates a network of cancer treatment facilities, including locations in Boca Raton, Florida; Chula Vista, California; and Hyderabad, India. CTSI specializes in services such as radiation oncology, medical oncology, surgical oncology, and full-service diagnostics, along with various support care services. The organization employs a centralized management approach that standardizes clinical pathways and operational processes, enhancing decision-making and ensuring a patient-centric environment. Initially focused on outpatient radiation therapy and medical oncology, CTSI aims to expand its offerings across multiple medical specialties, particularly in emerging markets.

CyberHeart, Inc. is a clinical development-stage company based in Mountain View, California, focused on creating a non-invasive robotic ablation treatment for cardiac arrhythmias, including conditions like atrial fibrillation and ventricular tachycardia. The company's flagship product, the CyberHeart System, utilizes advanced technology to dynamically detect, track, and compensate for the movement of both the heart and the patient, ensuring precise radiation delivery. This system is designed for use by healthcare professionals such as radiation oncologists, medical physicists, electrophysiologists, and cardiac surgeons. Founded in 2003 and operating as a subsidiary of Varian Medical Systems as of April 2019, CyberHeart has been conducting pre-clinical studies to validate the feasibility of its innovative technology. The company has also secured venture capital financing to support its development efforts.

HistoSonics, Inc. is a medical technology company based in Plymouth, Minnesota, specializing in non-invasive tumor ablation systems. The company has developed the Edison Platform, which employs advanced imaging and proprietary sensing technology to deliver precise sonic beam therapy. This innovative platform utilizes histotripsy and focused sound energy to liquefy and destroy targeted tissues at the sub-cellular level, enabling personalized treatments. HistoSonics' technology allows physicians to monitor the treatment in real time, offering a safe alternative to traditional interventional and surgical methods, minimizing undesirable side effects often associated with these approaches. Incorporated in 2009, HistoSonics aims to enhance treatment outcomes through its pioneering non-invasive solutions.

ABK Biomedical combines the clinical market with biomaterials. It specializes in improving treatment options for patients with hypervascular tumors. The company is dedicated to transforming an interventional radiology procedure called embolization.

Fusion Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company headquartered in Hamilton, Canada, specializing in the development of radiopharmaceuticals as precision medicines for challenging cancers. The company employs its proprietary Targeted Alpha Therapies platform and Fast-Clear linker technology to connect alpha particle-emitting isotopes to antibodies, enabling the selective delivery of therapeutic agents to tumors. Fusion's lead product candidate, FPI-1434, is currently undergoing Phase 1 clinical trials as a monotherapy for solid tumors expressing insulin-like growth factor 1 receptor. Additionally, the company is exploring the use of FPI-1434 in combination with approved checkpoint inhibitors and DNA damage response inhibitors in preclinical studies to enhance anti-tumor activity. Fusion is also advancing another product candidate, FPI-1966, into clinical development for head and neck and bladder cancers that express fibroblast growth factor receptor. Founded in 2014 as a spinout of the Centre for Probe Development and Commercialization, Fusion aims to transform how cancers are treated through innovative radiochemistry techniques.

Noona Healthcare Oy is a Finnish company that specializes in a web-based mobile platform designed for monitoring the wellbeing of breast cancer patients. Founded in 2014 and based in Helsinki, Noona allows patients to report symptoms related to their treatment directly to their healthcare providers through mobile devices, tablets, and computers. This real-time communication enhances the patient-clinic relationship, enabling clinical staff to promptly address severe symptoms and improve overall care quality. The platform also supports researchers in developing new cancer therapies by integrating digital data with patient diagnosis, treatment, and genetic information. As a result, Noona Healthcare contributes to better patient outcomes and optimizes resource allocation in oncology care. The company operates as a subsidiary of Varian Medical Systems, Inc.

HumediQ, founded in 2010, is a company focused on the development, production, and sales of medical-technical systems, particularly in the realm of quality assurance for radiotherapy. With a team of ten employees, the company specializes in creating automated systems that enhance patient identification, positioning, and motion management during radiation therapy. Their product features include a palm reader for accurate patient identification, automatic synchronization with oncology information systems, and surface-guided radiation therapy (SGRT) cameras that ensure proper patient positioning and monitor motion throughout treatment. HumediQ collaborates closely with hospitals and research institutions to integrate scientific research into clinical practice, aiming to improve the quality of medical devices and enhance treatment outcomes for patients.

Gamma Basics specializes in developing software applications tailored for the radiation oncology, nuclear medicine, and diagnostic imaging sectors. The company is known for grayCAD, a unique medical radiation safety computer-aided design software that allows users to design and analyze radiation shielding by utilizing architectural drawings and adhering to local shielding regulations. This software aids hospitals in evaluating their compliance with radiation safety standards, particularly when they upgrade their capital equipment. By focusing on enhancing safety protocols in medical environments, Gamma Basics plays a crucial role in ensuring that healthcare facilities meet regulatory requirements in radiation protection.

Cooperative CL Enterprises, a distributor of radiotherapy equipment in Taiwan. COOP currently employs 45 people, and has represented Varian in Taiwan for more than 40 years.

Evinance is a developer of clinical decision support software aimed at enhancing patient-centric healthcare. The company's patented technology enables stateless decision support and adherence tracking, leveraging evidence-based guidelines from recognized organizations. By integrating seamlessly into clinical workflows, the Evinance Decision Support Platform facilitates improved communication between doctors and patients through virtual patient paths, promoting collaborative decision-making. This modular platform supports various medical specialties and is adaptable to any electronic health record system, ensuring its versatility across healthcare settings. Headquartered in Montreal, Quebec, Evinance focuses on empowering clinicians, healthcare systems, and patients to make informed healthcare decisions together.

Mobius Medical Systems, based in Houston, Texas, specializes in developing radiation oncology quality assurance (QA) software aimed at improving treatment outcomes in cancer care. Founded in 2010, the company has established itself as a leader in the field, with its software utilized at over 1,000 sites globally to ensure the delivery of high-quality patient care. Key offerings include Mobius3D, a 3D dose verification system that supports verification checks throughout the clinical process for intensity-modulated radiation therapy (IMRT) and volumetric modulated arc therapy (VMAT). Additionally, DoseLab provides straightforward and effective QA for medical linear accelerators. As of 2018, Mobius Medical Systems operates as a subsidiary of Varian Medical Systems, further strengthening its impact in the radiation oncology sector.

Arterys Inc. is a technology company that specializes in developing a cloud-based analytics platform designed to enhance medical imaging diagnostics. Founded in 2007 and headquartered in San Francisco, California, with additional offices in Calgary and Paris, Arterys offers a range of artificial intelligence solutions, including Cardio AI for cardiac image analysis, Lung AI for lung imaging, and Liver AI for liver assessments. Their platform provides radiologists with tools to visualize and quantify blood flow in the human body, facilitating improved patient care through advanced imaging techniques. The Arterys PHI Service allows physicians to access patient data remotely, enhancing the efficiency of medical practice. As a pioneer in internet-based medical imaging, Arterys combines web accessibility with FDA-cleared AI technology to deliver innovative clinical solutions aimed at transforming healthcare.

Fusion Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company headquartered in Hamilton, Canada, specializing in the development of radiopharmaceuticals as precision medicines for challenging cancers. The company employs its proprietary Targeted Alpha Therapies platform and Fast-Clear linker technology to connect alpha particle-emitting isotopes to antibodies, enabling the selective delivery of therapeutic agents to tumors. Fusion's lead product candidate, FPI-1434, is currently undergoing Phase 1 clinical trials as a monotherapy for solid tumors expressing insulin-like growth factor 1 receptor. Additionally, the company is exploring the use of FPI-1434 in combination with approved checkpoint inhibitors and DNA damage response inhibitors in preclinical studies to enhance anti-tumor activity. Fusion is also advancing another product candidate, FPI-1966, into clinical development for head and neck and bladder cancers that express fibroblast growth factor receptor. Founded in 2014 as a spinout of the Centre for Probe Development and Commercialization, Fusion aims to transform how cancers are treated through innovative radiochemistry techniques.

Varex's components are used in medical imaging as well as in industrial and security imaging applications. Global OEM manufacturers.

Candela's radiotherapy business is a distributor of radiotherapy equipment in Poland.

TrueBeam systems will enable us to make advanced cancer care accessible to even more patients.

MeVis Medical Solutions AG is a provider of software solutions focused on the analysis and evaluation of medical imaging data, catering to equipment manufacturers and medical IT platform providers in the United States and Europe. The company operates in two primary segments: Digital Mammography and Other Diagnostics. The Digital Mammography segment develops software to support breast diagnostic imaging and interventions, including applications for various imaging modalities like ultrasound and magnetic resonance imaging. The Other Diagnostics segment offers digital radiology products aimed at diagnosing conditions such as lung, prostate, and intestinal disorders, alongside general image analysis services. Additionally, MeVis provides interactive online training to enhance diagnostic capabilities for clinical users. Founded in 1992 and based in Bremen, Germany, MeVis Medical Solutions operates as a subsidiary of Varex Imaging Deutschland AG.

Transpire, Inc. develops simulation software products that predict the macroscopic behavior of radiation for various industries.

Velocity Medical Solutions, provides intelligent radiation treatment tools for oncologists. It specializes in oncology PACS with wide applicability to the research, clinical, and drug discovery markets. The company offers VelocityAI, an imaging informatics software tool that enables rapid creation of radiation therapy plans and provides new methods to assess the effectiveness of therapy; VelocityGRID, a vendor-neutral platform that integrates image, structure, plan, and dose data, regardless of origin to create a unified patient dataset; and VelocityConnect that provides a platform for collaboration with referring physicians.

AppCompTech is a software development company focused on a life sciences application in Radiation Treatment Planning for Cancer Therapy. In 2010 an estimated 1.4 million Americans will be diagnosed with cancer and approximately 65% of those cancer victims will receive some form of radiation therapy.

Infimed, Inc. provides software and hardware for medical imaging. The company specializes in digital medical imaging systems for fluoroscopy, angiography, cardiology, general radiography, and digital radiography. It offers i5 DR, a digital radiography imaging system for dealers and OEM; and i5 RF/DSA, a digital fluoroscopy imaging system to acquire, review and alter, store, export, and print images. The company also provides iCynergy to acquire RF camera and static wireless DR panel images; PlatinumOne that improves the productivity of fluoroscopy, angiography, urology, and cardiology procedures; and i5 Nexus-DRF that includes InfiVision, an automatic image enhancement software. It serves customers in Asia, Europe, North America, the Russian Federation, China, and South America. The company was founded in 1983 and is based in Liverpool, New York. As of April 3, 2012, Infimed, Inc. operates as a subsidiary of Varian Medical Systems Inc

Calypso Medical Technologies is a Seattle-based, privately held medical device company. The Company's proprietary tumor localization system utilizes miniaturized implanted devices (Beacon® electromagnetic transponders) to continuously, accurately and objectively track the location of tumors for improved accuracy and management of radiation therapy delivery. The technology is designed for body-wide cancers commonly treated with radiation therapy. The products are FDA 510(k) cleared for use in the prostate and post-operative prostatic bed. The Company has strategic relationships with Varian Medical Systems, Siemens Medical Systems, Elekta Corporation, and Philips Medical.

SpaceOAR is a privately held medical device company developing in-situ formed, space-filling hydrogels specifically for radiation oncology and cancer surgery indications. Its hydrogel is clinically proven to minimize side effects and protect the quality of life for prostate cancer patients undergoing radiation therapy that enables healthcare providers to minimize urinary, sexual, and bowel side effects of the patients. It was founded in 2007 and is headquartered in Bedford, Massachusetts.

IKOEngelo, a medical knowledge-based system that enables the practice to operate IMRT at various levels of quality and efficiency.

Pan-Pacific Enterprises, Inc. distributes medical diagnostic equipment in China, the United states, and internationally.

Bio-Imaging Research. designs and manufactures medical and industrial imaging systems for medical‚ industrial‚ and security applications.

ACCEL Instruments GmbH, a privately held supplier of scientific research instruments and proton therapy systems for cancer treatment.

Sigma Micro Informatique Conseil, a privately-held company that is the leading supplier of information management software for radiation oncology and medical oncology in cancer clinics and hospitals in France and other European nations. Varian paid approximately $13 million in cash to acquire the company, which is based in Toulouse, France.

OpTx Corporation develops solutions for oncology practices in the areas of patient management.

Zmed, Inc. supplies stereotactic radiosurgery and precision radiotherapy products.Developer of radiation oncology software intended to improve clinical performance in medical imaging intensive applications. The company supplies radiation oncology software and accessories for ultrasound-based, image-guided radiotherapy (IGRT), stereotactic radiation treatments and image management.

MRW GmbH, a prominent reloader and distributor of medical X-ray tubes in Germany.

HDR brachytherapy a minimally invasive procedure for eradicating cancerous tumors with radiation.

Argus Software, Inc designs and develops quality control information management software.

IMPAC Medical Systems, Inc. specializes in providing information technology solutions for cancer care across North America, Europe, and Asia. The company offers a range of products including device connectivity systems, medical imaging solutions, practice management systems, anatomic pathology systems, and data aggregation and reporting tools. These offerings are designed to deliver integrated clinical and administrative solutions that address the complexities of cancer care, from detection and diagnosis to treatment and follow-up. Additionally, IMPAC provides services such as implementation, training, support, upgrades, transition management, network services, and remote hosting. Through its comprehensive oncology management system, IMPAC aims to enhance clinical and business operations, ultimately improving the efficiency and quality of patient care in healthcare facilities.

Multimedia Medical Systems, Inc. of Charlottesville, Va., to expand its product line for addressing the treatment of prostate cancer.

dpiX is a a-Si technology firm that focuses on research, engineering, development, and manufacturing.